Clinical Trial Update: Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection [Phase 3]

View source ↗

Summary

Phase 3 study update for Lenacapavir as HIV pre-exposure prophylaxis in at-risk individuals, with results posted on 2025-09-17 and the trial currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lenacapavir (lenacapavir)

Snippet

Sponsor: Gilead Sciences | Conditions: Pre-Exposure Prophylaxis of HIV Infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-09-17